Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech and RainDance to Co-Market Microdroplet PCR for Targeted Sequencing on SOLiD

Premium

RainDance Technologies and Life Technologies' Applied Biosystems unit have penned a strategic co-marketing agreement, the companies said last week.

Under the agreement, the firms will co-market RainDance's RDT 1000 sequence enrichment solution, which is based on microdroplet PCR, with ABI's SOLiD system.

In addition, the companies will continue to collaborate to use RainDance products in the SOLiD sequencing workflow.

Researchers at the Translational Genomics Research Institute in Phoenix, Ariz., have already used RainDance's enrichment technology in conjunction with SOLiD sequencing to identify somatic mutations in tumor samples, the companies said.

Both technologies "worked smoothly and offered superb coverage and accuracy," said John Carpten, a senior investigator and director of the Integrated Cancer Genomics Division at TGen, in a statement. "We are looking forward to expanding our use of both the RainDance and SOLiD platforms to other large-scale sequencing projects."

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.